Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H25ClO2 |
Molecular Weight | 344.875 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]3([H])[C@@]2([H])C=C(Cl)C4=CC(=O)C=C[C@@]34C
InChI
InChIKey=USXVMPAWZOOYDE-OAYGGAORSA-N
InChI=1S/C21H25ClO2/c1-12(23)15-4-5-16-14-11-19(22)18-10-13(24)6-8-21(18,3)17(14)7-9-20(15,16)2/h6,8,10-11,14-17H,4-5,7,9H2,1-3H3/t14-,15+,16-,17+,20+,21-/m0/s1
Molecular Formula | C21H25ClO2 |
Molecular Weight | 344.875 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Trengestone is a steroid substance, a retroprogesterone. It has a strong progestogenic action and stimulating effect on the hypotalamo-hypophyseal system. It does not possess a direct oestrogenic or androgenic action. It indirectly stimulates the oestrogen productivity in the ovary via the central nervous system. The mechanism of action for induction of ovulation is not clear. It is indicated for the treatment of normooestrogenic anovulation. Ovulation occurs after trengestone administration either immediately ater termination of treatment or much later. Another indication for its administration are other functional disorders of the cycle and treatment of imminent abortion. Side-effects are: mastalgia, headache and fatigue.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:33 GMT 2023
by
admin
on
Fri Dec 15 15:42:33 GMT 2023
|
Record UNII |
VY6S496SVX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C776
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID101023713
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
2757
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
3623
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
m11016
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
5192-84-7
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
C66621
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
56840930
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
225-978-8
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107518
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
VY6S496SVX
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
Trengestone
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
SUB11233MIG
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY | |||
|
100000077501
Created by
admin on Fri Dec 15 15:42:33 GMT 2023 , Edited by admin on Fri Dec 15 15:42:33 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |